Journal Articles Highlight Massive Financial Potential of BioTime’s HyStem and Galectin Therapeutics
For the last several weeks, I've been in my eye surgeon's office nearly every day, sometimes twice a day, for tests and treatments. I take calls between sessions and have a journal article open on my phone most of the time. This has led to the half-joking suggestions from the medical staff that I use an empty office in the clinic for my work.
It's odd because I feel fine now that we've discontinued several medications that were provoking bizarre and serious side effects. I've always, incidentally, reacted oddly to drugs, which is one of the reasons that I think that genome sequencing and bioinformatics are going to yield terrific advances in personalized medicine.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.